1Eccles SA, Welch DR. Metastasis : recent discoveries and novel treat- ment strategies[ J ]. Lancet, 2007, 369 (9574) : 1742 - 1757.
2Liu Y, Dean DC. Tumor initiation v/a loss of cell contact inhibition versus Ras mutation: do 'all roads lead to EMT[ J ] ? Cell Cycle, 2010, 9(5) : 897 -900.
3Curran S, Dundas SR, Buxton J, et al. Matrix metallop roteinase/ tissue inhibitors of matrix metallop roteinase phenotype identifies poor p rognosis colorectal cancer[J]. Clin Cancer Res, 2004, 10(24) : 8 - 29.
5Bagels CL and Tsongalis GJ. MicroRNAs: novel biomarkers for human cancer. Ann Biol Clin (Paris) 2010, 68:263-272 [Article in French].
6Kunej T, Godnic I, Horvat S, Zorc M and Calin GA. Cross talk between micmRNA and coding cancer genes. Cancer J 2012, 18: 223-231.
7Agostini M, Pucciarelli S, Calore F, Bedin C, Enzo M and Nitti D. miRNAs in colon and rectal cancer: a consensus for their true clinical value. Clin Chim Acta 2010, 411:1181-1186.
8Dong Y, Wu WK, Wu CW, Sung JJ, Yu J and Ng SS. MicmRNA dysregu- lation in colorectal cancer: a clinical perspective. Br J Cancer 2011, 104: 893-898.
9Heneghan HM, Miller N and Kerin MJ. MiRNAs as biomarkers and them- peutic targets in cancer. Curt Opin Pharrnacol 2010, 10: 543-550.
10Manne U, Shanmugam C, Bovell L, Katkoori VR and Bumpers HL. miRNAs as biomarkers for management of patients with colorectal cancer. Biomark Med 2010, 4:761-770.
3Shino Y,Watanabe A,Yamada Y,et al.Clinicopathologic evaluation of immunohistochemical E-cadherin expression in human gastric carcinomas[J].Cancer,1995,76 (11):2193-2201.
4Ross JS,Del-Rosario AD,Figge HL,et al.E-cadherin expression in papillary transitional cell carcinoma of the urinary bladder[J].Hum Pathol,1995,26(9):940-944.
6Shelley MD, Cleves A, Wilt TJ, et al. Gemcitabine ehemotherapy for the treatment of metastatic bladder carcinoma[J].BJ U Int, 2011,108(2) : 168-179.
7Du P, Ye L, Ruge F, et al. Metastasis suppressor-l, MTSS1, acts as a putative tumour suppressor in human bladder cancer [J].Anticancer Res,2011,31(10) :3205-3212.
8Muramaki M, Miyake H, Terakawa T, et al. Expression profile of E-cadherin and N-cadherin in non-muscle-invasive bladder cancer as a novel predictor of intravesical recurrence following transurethral resection E J 1. Urol Oncol, 2012, 30 (2):161-166.
9Siegel R, Naishadham D, Jemal A. Cancer statistics, 2012 [J]. CA Cancer J Clin, 2012, 62(1): 10-29.
10Jin F, Xie Z, Kuo C J, et al. Cotargeting tumor and tumor endothelium effectively inhibits the growth of human prostate cancer in adenovirus-mediated antiangiogenesis and oncolysis combination therapy [J]. Cancer Gene Ther, 2005, 12(3): 257-267.
